Bliv Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: compounded semaglutide or tirzepatide approved online with no phone or video visit, plus pay-later options
Bliv scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Tirzepatide
Price checked on Bliv’s site,
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Telehealth provider focused on personalized GLP-1 weight loss programs.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Bliv
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Bliv at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $116/mo (starting dose)
- What's included
- Medication · Shipping
- FDA status
- 1 FDA warning letter on record; see below
How we scored Bliv
Each dimension is scored algorithmically from Bliv’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.7/10At $116/mo (starting dose), Bliv runs about 35% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.2/10Bliv offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
5.4/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
6.2/10Bliv's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.0/10Bliv provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Bliv review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $116–$199/mo across 2 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with Bliv
We walked Bliv’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a quick medical intake online.
- 2A US-licensed provider securely reviews it with no phone calls and no video visit.
- 3If approved, a prescription for semaglutide or tirzepatide is issued.
- 4Medication is filled by a US pharmacy and shipped in discreet packaging, typically within 3-5 days.
- Pricing shown before intake but with 'as low as' eligibility caveats: semaglutide as low as $116/month, tirzepatide as low as $199/month.
- Explicitly no phone calls and no video visit for the intake.
- Offers pay-later financing (CareCredit/Klarna) from as low as $29/month.
- A refund policy is linked, but its details are not shown.
- Shipping typically within 3-5 days in discreet packaging.
Bliv customer support
- Phone
- 888-859-2882
GLP-1 medications Bliv offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often, so check Bliv's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Bliv: a bargain-priced GLP-1 program that keeps its cards close
Bliv is one of the most aggressively priced compounded GLP-1 sellers around, leading with compounded semaglutide at $116 a month (starting dose). That number alone will put it near the top of a lot of price-sorted shopping lists. For cost-first shoppers, that is the whole pitch. But Bliv is also one of the more tight-lipped providers in this space: it publishes a price and a short list of perks, then leaves most of the program mechanics undescribed. What you get is a low headline rate with a thin paper trail behind it, so check what is missing before you buy.
How the pricing works
Bliv frames its rate as 'as low as $116 per month (starting dose)' for compounded semaglutide. 'As low as' usually signals an introductory or lowest-dose figure rather than a flat rate you pay forever, so treat $116 (starting dose) as the entry point and don't count on it as a lifetime price. By contrast, Cielo charges the same price at every dose, so its rate stays put as you titrate. Tirzepatide, the dual-action molecule in Mounjaro and Zepbound, starts at $199 a month. For context, the category median sits at $179 a month, so even Bliv's tirzepatide line comes in well below what a typical competitor charges, and its semaglutide rate is a fraction of it.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
The medication price is the product price here. Bliv sells the drug itself rather than burying it inside a separate membership tier. Free shipping is included, and the company advertises 'no contracts,' meaning you are not locked into a multi-month commitment up front. What Bliv leaves unclear is whether a provider consult is baked into that monthly figure or billed separately. Before you sign up, confirm whether the visit with the prescriber is part of the price or an add-on.
The medications and how they're dispensed
Bliv offers compounded semaglutide and compounded tirzepatide, the same two active ingredients in the brand-name injectables, made by a compounding pharmacy rather than the original manufacturer. Compounded versions exist because they can be sold far cheaper, which is exactly how Bliv hits these prices. The trade-off is that compounded drugs are not FDA-approved products; they are permitted under specific pharmacy rules, and quality rides entirely on the pharmacy doing the work.
Bliv says little about that pharmacy. It does not name the compounding pharmacy that fills its prescriptions, nor does it publish accreditation details (such as a 503A or 503B designation or board status). That doesn't mean the supply is bad; plenty of legitimate sellers use reputable 503-class pharmacies. It does mean you can't check the source yourself. If a named pharmacy matters more to you, Lumen Meds says its medication comes from The Pharmacy Hub in Florida. With compounded GLP-1s, the source matters more than anything else.
What Bliv offers, and what it leaves out
Bliv competes on price and simplicity. It strips the offer down to a low number, free shipping, no contract, and phone support. There is no sprawling membership ladder, no bundled coaching upsell visible, no confusing à-la-carte menu. For someone who just wants the medication at the lowest defensible price and a human to call, that minimalism is the appeal.
The phone line helps because many budget telehealth brands route everything through chat or email. A published number is a small trust signal: there is someone to reach if a shipment is late or a dose question comes up.
The flip side is how much Bliv doesn't tell you. The state-availability map isn't disclosed on the site; the company directs you to email support to find out whether it serves your state. That gap matters because GLP-1 telehealth is regulated state by state, and you can't confirm Bliv even operates where you live without contacting them first.
- Where you get clarity: price for both drugs, free shipping, no contract, phone support.
- Where you don't: the compounding pharmacy and its accreditation, whether a consult fee is separate, which states are served, and the details of medical oversight.
Who should choose Bliv, and who should skip it
Bliv makes sense if you are paying cash, the price is your top filter, and you are comfortable doing a little homework: emailing support to confirm your state, asking which pharmacy fills the order, and clarifying whether the consult is included. If you've used compounded GLP-1s before and know what questions to ask, you'll know how to check the rest and keep the savings.
Skip it if you want everything documented before you hand over a card. Shoppers who need to see the pharmacy's accreditation, a published state list, and a clear breakdown of what the visit costs will reasonably find Bliv's silence uncomfortable. Anyone who specifically wants brand-name Wegovy, Ozempic, or Zepbound should also look elsewhere, since Bliv is a compounded-only offering.
Trust, safety, and medical oversight
Bliv has an FDA warning letter on file (February 2026, for false and misleading claims), covered in the regulatory notice on this page. Beyond that letter, Bliv discloses little about how oversight works: no named pharmacy, no accreditation, no public detail on how prescribing is supervised. The prices and the perks are right there on Bliv's website, but the program's clinical guts remain a black box. You can read more about how we weigh these signals in our scoring methodology.
Bottom line
Bliv is a price-led, no-frills way into compounded semaglutide and tirzepatide, and at $116 a month (starting dose) it undercuts most of the field by a wide margin against the $179 category median. What it lacks is information: undisclosed states, an unnamed pharmacy, and unclear consult terms mean you have to chase down the basics yourself before trusting it. If you'll make that one phone call or email, Bliv can be a cheap option. If you want the answers handed to you up front, a more transparent provider may justify the extra cost.
The Bottom Line
Bliv scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Bliv?
From $116/mo (starting dose). See current pricing and start your free consultation.
Bliv might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Bliv vs…
Bliv scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
Bliv vs Amazon One Medical
Amazon One Medical scores 8.5/10

Bliv vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Bliv received an FDA warning letter dated February 20, 2026
The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Bliv review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Bliv's current pricing
Plans from $116/mo (starting dose). Start your free consultation to check eligibility and today's price.